Select for export The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/jat.4533 PubMed 37646119 Copy citation Copy BibTeX Journal of Applied Toxicology 2023-08-29 Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0022 PubMed 40046569 Copy citation Copy BibTeX Psychedelic Medicine 2023-08-17 Antonio F. Pagán, Claudia Lex, Jair C. Soares, Thomas D. Meyer OpenAlex Published psilocybin DepressionChronic PainObservational Study Clinical Trial More
Select for export “But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/eat.24041 PubMed 37551650 Copy citation Copy BibTeX International Journal of Eating Disorders 2023-08-07 Amanda E. Downey, Maxine Boyd, Anita V. Chaphekar, Joshua Woolley, Marissa Raymond-Flesch OpenAlex Published psilocybin Eating DisordersChronic PainClinical Trial Clinical Trial More
Select for export Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bpsc.2023.07.003 PubMed 37459910 Copy citation Copy BibTeX Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2023-07-16 Flora Moujaes, Nathalie M. Rieser, Christophe Phillips, Nuno M.P. de Matos, Mike Brügger, P. Dürler OpenAlex Published psilocybin Chronic PainBrain ImagingMechanism of Action Other More
Select for export Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2023.535 PubMed 37489299 Copy citation Copy BibTeX BJPsych Open 2023-06-30 Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231179800 PubMed 37392016 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-06-29 Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Other More
Select for export Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1136990 PubMed 37457761 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-06-28 Winston De La Haye, G Walcott, Jordan Eaton, Jhoelle Beckford, Janelle D. Greene OpenAlex Published psilocybin Mechanism of ActionPersonality ChangeMystical Experience Clinical Trial More
Select for export HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer No abstract availability was recorded for this entry. Details DOI 10.1016/j.jpainsymman.2023.06.006 PubMed 37302533 Copy citation Copy BibTeX Journal of Pain and Symptom Management 2023-06-09 Benjamin R. Lewis, Eric L. Garland, Kevin Byrne, Tyler Durns, John Hendrick, Anna C. Beck OpenAlex Published psilocybin Chronic Pain Other More
Select for export Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231179910 PubMed 37291890 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-06-07 Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis Antoine, Sandeep M. Nayak OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/adb0000935 PubMed 37276086 Copy citation Copy BibTeX Psychology of Addictive Behaviors 2023-06-04 Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael A. Zingman, Katherine Kim, Alexandra Haas, Lindsey T. Owens OpenAlex Published psilocybin AddictionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0033291723001411 PubMed 37264950 Copy citation Copy BibTeX Psychological Medicine 2023-06-01 Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne Katrin Schlag, David Nutt OpenAlex Published psilocybin DepressionChronic PainToxicity Other More
Select for export How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2023.04.105 PubMed 37146908 Copy citation Copy BibTeX Journal of Affective Disorders 2023-05-02 Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, Robin Carhart-Harris OpenAlex Published psilocybin AnxietyChronic Pain Other More
Select for export Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2022-068884 PubMed 37142308 Copy citation Copy BibTeX BMJ Open 2023-04-30 Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta OpenAlex Published psilocybin AnxietyPTSDChronic Pain Clinical Trial More
Select for export Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1178529 PubMed 37181888 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-04-24 Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico OpenAlex Published psilocybin OCDChronic PainBrain Imaging Randomized Controlled Trial More
Select for export A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231167848 PubMed 37122239 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-04-24 Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0002 PubMed 40046727 Copy citation Copy BibTeX Psychedelic Medicine 2023-04-18 Stephanie Lake, Philippe Lucas OpenAlex Published psilocybin WellbeingObservational StudyToxicity Observational Study More
Select for export Use of Selective Alternative Therapies for Treatment of OCD. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/ndt.s403997 PubMed 37041856 Copy citation Copy BibTeX Unknown journal 2023-04-04 Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S Europe PMC Published psilocybin OCDMechanism of ActionClinical Trial Systematic Review More
Select for export Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2023.109528 PubMed 37015315 Copy citation Copy BibTeX Unknown journal 2023-04-01 Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS Europe PMC Published psilocybin DepressionAddictionChronic Pain Clinical Trial More
Select for export Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231154852 PubMed 36938991 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-19 Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1123424 PubMed 36998623 Copy citation Copy BibTeX Unknown journal 2023-03-13 Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
